Founded 1999 in Santa Fe, New Mexico Proprietary technology from - - PowerPoint PPT Presentation

founded 1999 in santa fe new mexico proprietary
SMART_READER_LITE
LIVE PREVIEW

Founded 1999 in Santa Fe, New Mexico Proprietary technology from - - PowerPoint PPT Presentation

Founded 1999 in Santa Fe, New Mexico Proprietary technology from Los Alamos National Laboratory Technology was developed to detect specific bio-molecular events or interactions in biochemical compound screening assays Two


slide-1
SLIDE 1
slide-2
SLIDE 2
  • Founded 1999 in Santa Fe, New Mexico
  • Proprietary technology from Los Alamos

National Laboratory

  • Technology was developed to detect specific

bio-molecular events or interactions in biochemical compound screening assays

  • Two business unit focuses

– Drug Discovery and HTS assays – Biodefense and biotoxin detection

  • Company has a staff of 26, with 14 Ph.D’s
slide-3
SLIDE 3

Technology:

  • Detection system consists of a fluorescent polymer and

quencher-tether-ligand (QTL) moieties

  • The QTL moieties consist of a quencher that quenches

polymer fluorescence, a ligand that is specifically cleaved by target enzyme, and a tether that connects the quencher and ligand

  • When the reactive tether is cleaved by enzyme, the

quencher is released from the polymer, resulting in a quantitative signal that increases with enzyme activity

  • r duration of the assay
  • Inhibitors of the enzyme modulate this signal increase,

which can be tuned over a variety of sensitivity ranges as desired by target sensitivity requirements

slide-4
SLIDE 4
  • Technology:

+ +

Polym er Quenched No Quench Enzym e Peptide Substrate Biotin Recognition Sequence Quencher Fluorescent Polym er Coated M icrospheres

+

Biotin Binding Protein

+ +

Polym er Quenched No Quench Enzym e Peptide Substrate Biotin Recognition Sequence Quencher Fluorescent Polym er Coated M icrospheres

+

Biotin Binding Protein

slide-5
SLIDE 5
  • Technology has led to the development and

release of HTS and Drug Discovery target specific assays:

slide-6
SLIDE 6
  • First commercially available assay:
  • Applied to Alzheimer’s disease research
  • Major constituent of senile plaques associated

with Alzheimer’s is the β-amyloid peptide, generated by the activity of the enzyme β- secretase in the human brain

  • Combines speed with sensitivity for screening

potential inhibitors against β-secretase

slide-7
SLIDE 7
  • Format is single-step, instantaneous, and

homogenous

  • Fluorescense based assays
  • Assay can be read with most commercially

available fluorescence spectrometers or multi- well plate readers

  • The excitation (blue) and detection (green)

wavelengths are compatible with all common fluorimeters

slide-8
SLIDE 8
  • Typical assay workflow:

– Dispense target enzyme, substrate & compounds to wells – Add sensor (fluorescent polymer) – Read fluorescence

slide-9
SLIDE 9
  • Advantages of technology:

– Sensitivity - fluorescent polymers offer

advantages over conventional small molecule-based fluorescence assays – Polymers “harvest” light effectively both by absorption and by super-quenching – even sub- nanomolar solutions of some of these material are visibly colored – Fluorescence can be detected at even lower concentrations – Polymers can be synthesized in repeat ranges of 3 to 1000 – Polymers provide 5 to 6 times the fluorescence signal of traditional FRET-based readouts

slide-10
SLIDE 10
  • Advantages of technology:

– Simplicity and Throughput - The assay format

does not require…

– Beads or washing steps – Radioactive compounds – Antibodies – Additional processing steps after all components have been added – Time to results from 10 minutes onwards depending on enzyme usage

slide-11
SLIDE 11
  • Applications:

– High-Throughput Screening for Alzheimer’s drugs – Research in Alzheimer’s Disease

slide-12
SLIDE 12
slide-13
SLIDE 13
  • Assay Performance at 20%

substrate conversion:

– S/B ……………1.70 – S/N ……………16 – CV % …………1.80 – Z′ ……………..0.74 – No. of repeats …4

slide-14
SLIDE 14

Enzyme concentration curve

1.0x10

5

0.8 0.6 0.4 Fluore sce nce Counts 60 50 40 30 20 10 [ BACE- 1] ( nM)

[ Substrate] = 1.2 µM 60 Min incubation 10 µL volume

slide-15
SLIDE 15

Time Response

8x10

4

6 4 2 Rela tive Fluore sce nce Counts 120 100 80 60 40 20 Time ( Minutes)

15 ng Enzyme 5 ng Enzyme

slide-16
SLIDE 16
slide-17
SLIDE 17

Other areas of interest:

  • Additional HTS Assays:

– Caspase 3,7 – Kinase Assays: Detection Platform

  • Assay Development Services

– Custom Enzyme and Protein-Protein Assays

  • Environmental Bio-detection

– QTL Biosensor™ for bacterial spores and protein toxins

slide-18
SLIDE 18
  • Contact information:
  • Sales and Business Development

Paul Gindlesperger Director of Sales and Marketing 505-424-1000, ext. 116 pgindlesperger@qtlbio.com www.qtlbio.com

slide-19
SLIDE 19